Clinical Factors and Characteristics that Affect Prognosis of COVID-19 Patients
Downloads
Background: COVID-19 disease has been linked to severe and deadly respiratory disease in various age groups. In team of COVID-19 disease prognosis and mortality, age is a key factor. The chance of mortality climbs from 0.66 percent to 7.8 percent in those over the age of 80. Males have a greater COVID-19 prevalence rate than females. Furthermore, even in the absence of additional comorbidities, sex was an essential biological determinant in prognosis and death risk among COVID-19 positive people. Another factor that influences the prognosis of COVID-19 illness is comorbidity. It's critical to comprehend the clinical characteristics and variables that influence the prognosis of COVID-19 illness patients. Objective: To describe the clinical factors and characteristics that affect COVID-19 patients’ prognosis. Methods: Retrospective research performed at Queen Alia Military Hospital by examining clinical characteristics of hospitalized individuals with a verified diagnosis of COVID-19 disease, as confirmed by polymerase-chain-reaction (PCR) assay. The research comprised laboratory outcomes, demographic features, chest imaging, and clinical data. Participants were categorized into the progression category and the improvement/stabilization group. Results: A total of 51 participants with a mean age of 33.6 years were involved in the research. Forty-six participants (90.2%) were categorized as an improvement/stabilization group, and five patients were classified as a progression group (9.8%). Fever, diarrhea, breath shortness, and cough were the most common signs and symptoms. Significant differences were detected between groups concerning age, comorbid diseases (diabetes and hypertension), disease severity, length of stay in the hospital, WBCs, creatinine, total bilirubin, ALP, LDH, CRP, albumin, oxygen saturation, and pulmonary consolidation (P < 0.05). Moreover, multivariate logistic regression determined age (OR, 1.79; CI: .950 3.28; P = 0.035), diabetes (OR, 1.62; CI: 1.02 - 4.19; P 0.012), hypertension (OR, 1.13; CI: 1.04 - 3.62; P =0.023), increased creatinine (OR, 3.57; CI: 2.30 - 6.71; P = 0.01), and increased total bilirubin (OR, 2.82; CI: 1.72 - 3.28; P = 0.031) as risk factors for disease progression. Conclusion: Chronic disease and abnormal creatinine and bilirubin level including other factors contribute to poor prognosis of COVID-19 patients. This study shows that the clinical characteristics of the patient should be prioritized in disease management.
Downloads
Report of clustering pneumonia of unknown etiology in Wuhan City. Wuhan Municipal Health Commission, 2019. As retrieved from (http://wjw.wuhan.gov.cn/front/web/ show Detail/2019123108989)
Zhu, Na, Dingyu Zhang, Wenling Wang, Xingwang Li, Bo Yang, Jingdong Song, Xiang Zhao et al. "A novel coronavirus from patients with pneumonia in China, 2019." New England journal of medicine , 2020.
Gorbalenya, Alexander E., Susan C. Baker, Ralph Baric, Raoul J. de Groot, Christian Drosten, Anastasia A. Gulyaeva et al. "Severe acute respiratory syndrome-related coronavirus: The species and its viruses–a statement of the Coronavirus Study Group." , 2020.
WHO. WHO Director general's remarks at the media briefing on SARS-CoV-2 on 16 March 2020. http://www.nhc.gov.cn/xcs/yqfkdt/202003/114113d25c1d47aabe68381e836f06a8.shtml.
Chan JW, Ng CK, Chan YH, Mok TY, Lee S, Chu SY, Law WL, Lee MP, Li PC. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome SARS. Thorax. 2003.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine. 2020.
Zhao XY, Xu XX, Yin HS, Hu QM, Xiong T, Tang YY, Yang AY, Yu BP, Huang ZP. Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study. BMC infectious diseases. 2020.
Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, Li P, Zhou Y, Lin YF, Duan Q, Luo G. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. Journal of Infection. 2020.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Yu T. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet. 2020.
Srivastava N, Baxi P, Ratho RK, Saxena SK. Global trends in epidemiology of coronavirus disease 2019 (COVID-19). InCoronavirus Disease 2019 (COVID-19) 2020.
Hamid S, Mir MY, Rohela GK. Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics). New microbes and new infections. 2020 .
Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, Cuomo-Dannenburg G, Thompson H, Walker PG, Fu H, Dighe A. Estimates of the severity of coronavirus disease 2019: a model-based analysis. The Lancet infectious diseases. 2020 .
Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020.
Meng Y, Wu P, Lu W, Liu K, Ma K, Huang L, et al. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients. PLoS Pathog. 2020.
Fei F, Ting Y, Ronghui D, Guohui F, Ying L, Zhibo L, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020.
Patanavanich R, Glantz SA. Smoking Is Associated With COVID-19 Progression: A Meta-analysis. Nicotine Tob Res. 2020.
Zhao Q, Meng M, Kumar R, et al. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis. J Med Virol. 2020.
Vardavas CI, Nikitara K. COVID-19, and smoking: A systematic review of the evidence. Tob Induc Dis. 2020.
Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987.
Liu W, Tao ZW, Wang L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J. 2020.
Wang L, He W, Yu X, et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020.
Jaillon S, Berthenet K, Garlanda C. Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol 2019.
Cilloniz C, Polverino E, Ewig S, Aliberti S, Gabarrus A, Menendez R, et al. Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. Chest 2013.
Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet 2020.
Schoen K, Horvat N, Guerreiro NFC, Giassiks I. Spectrum of clinical and radiographic findings in patients diagnosed with H1N1 and correlation with clinical severity. BMC Infect Dis 2019.
Song Z, Xu Y, Bao L, Zhang L, Yu P, et al. QinFrom SARS to MERS, thrusting coronaviruses into the spotlight. Viruses 2019.
Hui S, Azhar E, Kim Y, Memish Z, Oh M, Zumla A. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis 2018
Ip A, Parikh K, Parrillo JE, Mathura S, Hansen E, Sawczuk IS, Goldberg SL. Hypertension and renin–angiotensin–aldosterone system inhibitors in patients with Covid-19. MedRxiv. 2020.
Zaki N, Alashwal H, Ibrahim S. Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review. Diabetes Metab Syndr. 2020
Lippi G, Henry BM. Active smoking is not associated with the severity of coronavirus disease 2019 (COVID-19). Eur J Intern Med. 2020
Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020
Zhang J, Wang X, Jia X, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020.
Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020.
Diao B, Feng Z, Wang C, Wang H, Liu L, et al. Human kidney targets novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Med Rxiv; 2020.
Cai Q, Huang D, Yu H, et al. COVID-19: Abnormal liver function tests. J Hepatol. 2020.
Lu X, Jiang L, Chen T, et al. Continuously available SpO2/FiO2 serves as a noninvasive prognostic marker for intensive care patients with COVID-19. Respir Res. 2020.
Zhou S, et al. CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China AJR 2020.
Francone M, Iafrate F, Masci GM, Coco S, Cilia F, Manganaro L, Panebianco V, Andreoli C, Colaiacomo MC, Zingaropoli MA, Ciardi MR. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. European radiology. 2020 .
Copyright (c) 2022 International Journal of Scientific Research and Management
This work is licensed under a Creative Commons Attribution 4.0 International License.